We evaluated whether clinical features associated with the risk of death could identify men appropriate for observation without salvage ADT following postradiation PSA recurrence who would not suffer clinical progression to metastases prior to death from a nonprostate cancer cause. The gene discussed is KLK3; the disease is cancer.